ResMed Revenue 2006-2020 | RMD

ResMed annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ResMed revenue for the quarter ending March 31, 2020 was $0.769B, a 16.19% increase year-over-year.
  • ResMed revenue for the twelve months ending March 31, 2020 was $2.892B, a 14.51% increase year-over-year.
  • ResMed annual revenue for 2019 was $2.607B, a 11.38% increase from 2018.
  • ResMed annual revenue for 2018 was $2.34B, a 13.23% increase from 2017.
  • ResMed annual revenue for 2017 was $2.067B, a 12.4% increase from 2016.
ResMed Annual Revenue
(Millions of US $)
2019 $2,607
2018 $2,340
2017 $2,067
2016 $1,839
2015 $1,679
2014 $1,555
2013 $1,514
2012 $1,369
2011 $1,243
2010 $1,092
2009 $921
2008 $835
2007 $716
2006 $607
2005 $426
ResMed Quarterly Revenue
(Millions of US $)
2020-03-31 $769
2019-12-31 $736
2019-09-30 $681
2019-06-30 $705
2019-03-31 $662
2018-12-31 $651
2018-09-30 $588
2018-06-30 $624
2018-03-31 $592
2017-12-31 $601
2017-09-30 $524
2017-06-30 $557
2017-03-31 $514
2016-12-31 $530
2016-09-30 $465
2016-06-30 $519
2016-03-31 $454
2015-12-31 $455
2015-09-30 $412
2015-06-30 $453
2015-03-31 $422
2014-12-31 $423
2014-09-30 $380
2014-06-30 $415
2014-03-31 $398
2013-12-31 $384
2013-09-30 $358
2013-06-30 $415
2013-03-31 $384
2012-12-31 $377
2012-09-30 $340
2012-06-30 $372
2012-03-31 $349
2011-12-31 $333
2011-09-30 $315
2011-06-30 $342
2011-03-31 $313
2010-12-31 $306
2010-09-30 $282
2010-06-30 $292
2010-03-31 $279
2009-12-31 $275
2009-09-30 $247
2009-06-30 $252
2009-03-31 $228
2008-12-31 $223
2008-09-30 $218
2008-06-30 $235
2008-03-31 $212
2007-12-31 $203
2007-09-30 $186
2007-06-30 $191
2007-03-31 $183
2006-12-31 $178
2006-09-30 $164
2006-06-30 $171
2006-03-31 $162
2005-12-31 $146
2005-09-30 $127
2005-06-30 $125
2005-03-31 $108
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $27.789B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.573B 28.54
Medtronic (MDT) Ireland $121.803B 19.78
Stryker (SYK) United States $66.678B 21.64
Boston Scientific (BSX) United States $48.529B 22.82
Baxter (BAX) United States $43.229B 26.39
Lonza Group Ag (LZAGY) Switzerland $42.790B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.034B 0.00
Terumo (TRUMY) Japan $28.019B 35.82
Zimmer Biomet Holdings (ZBH) United States $24.651B 15.51
Sunny Optical Technology (SNPTF) China $19.798B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.859B 0.00
Bio-Rad Laboratories (BIO) United States $14.161B 64.46
Shandong Weigao Medical Polymer (SHWGF) China $13.702B 0.00
Insulet (PODD) United States $13.110B 1298.88
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.359B 81.40
GN STORE NORD (GNNDY) Denmark $7.527B 38.37
Perrigo (PRGO) Ireland $7.520B 13.46
Hill-Rom Holdings (HRC) United States $7.384B 20.82
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $6.112B 0.00
Haemonetics (HAE) United States $4.436B 26.64
Neogen (NEOG) United States $4.094B 69.35
GW Pharmaceuticals (GWPH) United Kingdom $3.971B 0.00
ICU Medical (ICUI) United States $3.820B 27.86
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.796B 0.00
Agios Pharmaceuticals (AGIO) United States $3.644B 0.00
Envista Holdings (NVST) United States $3.215B 0.00
NuVasive (NUVA) United States $2.805B 22.52
TG Therapeutics (TGTX) United States $2.618B 0.00
National Vision Holdings (EYE) United States $2.314B 40.03
AtriCure (ATRC) United States $1.753B 0.00
MacroGenics (MGNX) United States $1.500B 0.00
Aurora Cannabis (ACB) Canada $1.361B 0.00
NanoString Technologies (NSTG) United States $1.319B 0.00
Aphria (APHA) Canada $1.238B 0.00
Cerus (CERS) United States $1.120B 0.00
Cardiovascular Systems (CSII) United States $1.032B 0.00
Meridian Bioscience (VIVO) United States $1.025B 38.60
Phibro Animal Health (PAHC) United States $1.015B 20.24
PetIQ (PETQ) United States $0.992B 28.64
Vapotherm (VAPO) United States $0.983B 0.00
Zynex (ZYXI) United States $0.949B 95.27
DFB Healthcare Acquisitions (AHCO) United States $0.869B 144.62
OraSure Technologies (OSUR) United States $0.833B 167.81
InMode (INMD) Israel $0.826B 17.45
Quanterix (QTRX) United States $0.772B 0.00
Omeros (OMER) United States $0.742B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.50
BioLife Solutions (BLFS) United States $0.620B 176.55
VAREX IMAGING (VREX) United States $0.586B 14.54
Lantheus Holdings (LNTH) United States $0.573B 11.54
Surmodics (SRDX) United States $0.570B 68.62
LeMaitre Vascular (LMAT) United States $0.519B 29.57
Owens & Minor (OMI) United States $0.459B 12.13
Viemed Healthcare (VMD) United States $0.408B 36.17
Cytosorbents (CTSO) United States $0.367B 0.00
HEXO (HEXO) $0.334B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.330B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.93
Organigram Holdings (OGI) Canada $0.269B 0.00
InfuSystems Holdings (INFU) United States $0.224B 124.22
Female Health (VERU) United States $0.208B 0.00
Chimerix (CMRX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.136B 12.09
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
United Health Products (UEEC) United States $0.122B 0.00
Wound Management Technologies (SMTI) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Evolus (EOLS) United States $0.108B 0.00
MTech Acquisition (KERN) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.32
Trinity Biotech (TRIB) Ireland $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00